Nucleotide (GenBank) :
Ligation-independent cloning vector pBluescript II KS(+)/LIC, complete sequence.
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Size (kb): 3.0329999923706060
Vector: pGEM-7Zf(+)/LIC-F (phagemid)
Promoters: Promoter T7
Construct size (kb): 3.032999992370606
Features: insert detection: lacZ
vector permitting visual detection of recombinants
Restriction digests of the clone give the following sizes (kb): SmaI--2.95; EcoRI--2.95; BamHI--2.95.
Preparation of the vector for cloning includes linearization with NarI, gel purification of the linearized vector, and treatment with T4 DNA polymerase in the presence of dATP.
The target sequence can be amplified using sequence specific primers modified at the 5' end to contain an additional 13 nt complementary to the vector sequence.
The forward primer should contain 5'-CTGGTTCCGGCGA-3' followed by 12-15 nt target specific sequence. The reverse primer should contain 5'-CTCGCTCCGGCGA-3' followed by 12-15 nt target specific sequence.
Following amplification, the amplified sequence should also be gel purified and treated with T4 DNA polymerase in the presence of dTTP. Annealing of the vector and amplification product forms a duplex molecule that can be used directly for transformation.
Sequences amplified using these primers are also compatible with the pBluescript II KS(+)/LIC and pGEM-7Zf(+)/LIC-R vectors (ATCC 87047
Differs from pGEM-7Zf(+)/LIC-R (ATCC 87049)
only in the orientation of complementary ends generated at the cloning site.
Ligation-independent cloning vector.
Haun RS, et al. Rapid, reliable ligation-independent cloning of PCR products using modified plasmid vectors. BioTechniques 13: 515-518, 1992. PubMed: 1362067